A detailed history of Bridgeway Capital Management, LLC transactions in Pep Gen Inc. stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 48,700 shares of PEPG stock, worth $176,781. This represents 0.01% of its overall portfolio holdings.

Number of Shares
48,700
Previous 48,700 -0.0%
Holding current value
$176,781
Previous $777,000 46.46%
% of portfolio
0.01%
Previous 0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$10.54 - $18.14 $532,270 - $916,070
-50,500 Reduced 50.91%
48,700 $777,000
Q4 2023

Feb 14, 2024

BUY
$3.86 - $7.96 $165,594 - $341,484
42,900 Added 76.2%
99,200 $674,000
Q3 2023

Nov 14, 2023

BUY
$5.0 - $9.09 $281,500 - $511,767
56,300 New
56,300 $286,000

Others Institutions Holding PEPG

About PepGen Inc.


  • Ticker PEPG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 23,631,900
  • Market Cap $85.8M
  • Description
  • PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. The company's lead product candidate is PGN-EDO51, an EDO peptide in Phase I clinical trials to treat individuals with Duchenne muscular dystrophy (DMD). It is a...
More about PEPG
Track This Portfolio

Track Bridgeway Capital Management, LLC Portfolio

Follow Bridgeway Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.